Medical X-Press – Abraham Gutman
The Food and Drug Administration confirmed the shortage, which specifically affects the immediate-release formulation, earlier this month. Teva, a major manufacturer of generic drugs, including a generic version of Adderall, is “experiencing ongoing intermittent manufacturing delays,” the FDA said. Further complicating the issue: Adderall is considered a controlled substance because it contains amphetamine and dextroamphetamine, and its production is highly regulated.
Read More: https://medicalxpress.com/news/2022-10-adderall-shortage-psychiatrist-kids-adults.html